PCSK9 Inhibitors in Targeted Treatment of Hypercholesterolemia - April 26, 2016

Offered By: Mary Greeley Medical Center via YouTube

Course Description

Overview

Save Big on Coursera Plus. 7,000+ courses at $160 off. Limited Time Only!

Explore the latest advancements in treating hypercholesterolemia in this comprehensive Grand Rounds lecture delivered by Dr. Alan S. Brown, Director of the Division of Cardiology at Advocate Heart Institute. Delve into the role of PCSK9 inhibitors as part of a targeted treatment approach, gaining valuable insights from an expert in the field. Learn about the latest research, clinical applications, and potential benefits of this innovative class of drugs in managing high cholesterol levels. Enhance your understanding of cardiovascular medicine and stay up-to-date with cutting-edge therapeutic strategies in this hour-long presentation from the Mary Greeley Medical Center.

Syllabus

PCSK9 Inhibitors within the Targeted Treatment Approach to Hypercholesterolemia 4/26/16

Taught by

Mary Greeley Medical Center

Related Courses

Health in Numbers: Quantitative Methods in Clinical & Public Health Research
Harvard University via edX Health Informatics on FHIR
Georgia Institute of Technology via Coursera Data Management for Clinical Research
Vanderbilt University via Coursera Fundamentals of Clinical Trials
Harvard University via edX Practical tips to improve Asian American participation in cancer clinical trials
Stanford University via Coursera